Advertisement

Scavenger receptor type BI potentiates reverse cholesterol transport system by removing cholesterol ester from HDL

      Abstract

      High-density lipoprotein (HDL) plays an important role in reverse cholesterol transport by removing accumulated cholesterol from extrahepatic tissues. Subsequently, cholesterol ester (CE) on HDL in humans is transported to apolipoprotein B-containing lipoproteins by cholesteryl ester transfer protein (CETP). CETP deficiency, which is common in the Japanese population, leads to a marked increase in HDL-cholesterol levels due to impaired CE transport from HDL to LDL. It has been reported that the HDL observed in CETP deficiency is an atherogenic lipoprotein, as it contains a large amount of CE. Scavenger receptor class B type I (SR-BI) has been found to be an authentic HDL receptor that mediates the selective uptake of HDL CE and the bi-directional transfer of free cholesterol between HDL and cells. In the present study, the interaction between SR-BI and CE-rich HDL from CETP-deficient patient was studied in order to evaluate the anti-atherosclerotic role of SR-BI in relation to CE uptake and reverse cholesterol transport. When CE-rich HDL was added to the medium of SR-BI-transfected CHO (SR-BI CHO) cells, more CE accumulated in SR-BI CHO cells compared to control HDL. In contrast, the amount of cholesterol efflux from SR-BI CHO cells into HDL was almost the same between the two HDLs. Therefore, when CE-rich HDL was added to the medium of SR-BI CHO cells, the intracellular CE content increased significantly. Moreover, the particle size of HDL in CETP-deficient patient decreased significantly when the HDL was added to the medium of SR-BI CHO cells, and this HDL showed an increment of CE efflux from foam cells. These results indicate that SR-BI reduces the cholesterol content and size of the CE-rich HDL from CETP deficiency, which ultimately activate reverse cholesterol transport system.

      Abbreviations:

      apo (apolipoprotein), CE (cholesterol ester), CETP (cholesteryl ester transfer protein), LCAT (lecithin:cholesterol acyltransferase), LPDS (lipoprotein-deficient serum), SR-BI (scavenger receptor class B type I)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Eisenberg S
        High density lipoprotein metabolism.
        J. Lipid Res. 1984; 25: 1017-1058
        • Fielding C.J
        • Fielding P.E
        Molecular physiology of reverse cholesterol transport.
        J. Lipid Res. 1995; 36: 211-228
        • Tall A.R
        Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.
        J. Clin. Invest. 1990; 86: 379-384
        • Acton S
        • Rigotti A
        • Landschulz K.T
        • et al.
        Identification of scavenger receptor SR-BI as a high density lipoprotein receptor.
        Science. 1996; 271: 518-520
        • Krieger M
        The best of cholesterols, the worst of cholesterols: a tale of two receptors.
        Proc. Natl. Acad. Sci. U.S.A. 1998; 95: 4077-4080
        • Ng D.S
        • Francone O.L
        • Forte T.M
        • et al.
        Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.
        J. Biol. Chem. 1997; 272: 15777-15781
        • Rigotti A
        • Edelman E.R
        • Seifert P
        • et al.
        Regulation by adrenocorticotropic hormone of the in vivo expression of scavenger receptor class B type I (SR-BI), a high density lipoprotein receptor, in steroidogenic cells of the murine adrenal gland.
        J. Biol. Chem. 1996; 271: 33545-33549
        • Ji Y
        • Jian B
        • Wang N
        • et al.
        Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux.
        J. Biol. Chem. 1997; 272: 20982-20985
        • Arai T
        • Wang N
        • Bezouevski M
        • et al.
        Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene.
        J. Biol. Chem. 1999; 274: 2366-2371
        • Wang N
        • Arai T
        • Ji Y
        • et al.
        Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice.
        J. Biol. Chem. 1998; 273: 32920-32926
        • Yamashita S
        • Hui D.Y
        • Sprecher D.L
        • et al.
        Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect.
        Biochem. Biophys. Res. Comm. 1990; 170: 1346-1351
        • Inazu A
        • Brown M.L
        • Hesler C.B
        • et al.
        Increased high density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.
        N. Engl. J. Med. 1990; 323: 1234-1238
        • Koizumi J
        • Inazu A
        • Yagi K
        • et al.
        Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency.
        Atherosclerosis. 1991; 90: 189-196
        • Marotti K.R
        • Castle C.K
        • Boyle T.P
        • et al.
        Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein.
        Nature. 1993; 364: 73-75
        • Hayek T
        • Masucci-Magoulas L
        • Jiang X
        • et al.
        Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene.
        J. Clin. Invest. 1995; 96: 2071-2074
        • Oliveira H.C
        • Ma L
        • Milne R
        • et al.
        Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Studies in CETP transgenic mice and human genetic CETP deficiency.
        Arterioscler Thromb. Vasc. Biol. 1997; 17: 1045-1052
        • Ishigami M
        • Yamashita S
        • Sakai N
        • et al.
        Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency cannot protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins.
        J. Biochem. 1994; 116: 257-262
        • Zhong S
        • Sharp D.S
        • Grove J.S
        • et al.
        Increased coronary heart disease in Japanese–American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.
        J. Clin. Invest. 1996; 97: 2917-2923
        • Hirano K
        • Yamashita S
        • Nakajima N
        • et al.
        Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.
        Arterioscler. Thromb. Vasc. Biol. 1997; 17: 1053-1059
        • Fukasawa M
        • Adachi H
        • Hirota K
        • et al.
        SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apototic cells.
        Exp. Cell Res. 1996; 222: 246-250
        • Havel R.J
        • Eder H.A
        • Bragdon J.H
        The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.
        J. Clin. Invest. 1955; 34: 1345-1354
        • Roberts D.C.K
        • Miller N.E
        • Price S.G.L
        • et al.
        An alternative procedure for incorporating radiolabelled cholesteryl ester into human plasma lipoproteins in vitro.
        Biochem. J. 1985; 226: 319-322
        • Usui S
        • Nakamura M
        • Jitsukata K
        • et al.
        Assessment of between-instrument variations in a HPLC method for serum lipoproteins, and its traceability to reference methods for total cholesterol and HDL-cholesterol.
        Clin. Chem. 2000; 46: 63-72
        • Kinoshita M
        • Kawamura M
        • Maeda T
        • et al.
        Apolipoprotein E accelerates the efflux of cholesterol from macrophages: mechanism of xanthoma formation in apolipoprotein E deficiency.
        J. Athero. Thromb. 2000; 6: 22-27
        • Bligh E.G
        • Dyer W.J
        A rapid method of total lipid extraction and purification.
        Can. J. Biochem. Physiol. 1959; 37: 911-917
        • Lowry O.H
        • Rosebrough N.J
        • Farr A.L
        • et al.
        Protein measurement with the Folin phenol reagent.
        J. Biol. Chem. 1951; 193: 265-275
        • Yamashita S
        • Hui D.Y
        • Wetterau J.R
        • et al.
        Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition.
        Metabolism. 1991; 40: 756-763
        • Yamashita S
        • Sprecher D.L
        • Sakai N
        • et al.
        Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.
        J. Clin. Invest. 1990; 86: 688-695
        • Ueda Y
        • Royer L
        • Gong E
        • et al.
        Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice.
        J. Biol. Chem. 1999; 274: 7165-7171
        • Rigotti A
        • Trigatti B.L
        • Penman M
        • et al.
        A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism.
        Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 12610-12615